abrdn plc — Full Portfolio

CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.

BiotechHealthtechSan Carlos, US

AFAnthony Ford(Executive Officer, Director)inBenjamin Potter(Executive Officer)Henry Skinner(Director)LRLiam Ratcliffe(Director)in

BoardRHRon Hunt(Director)inLoretta Tse, Ph.D.(Director)

Co-investorsALAlta PartnersLOLongitude CapitalJOJohnson & Johnson Innovation – JJDCNENew Leaf Venture PartnersPAPappas CapitalCHChiesi Ventures+1 more

Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders.

BiotechDigital HealthMedical DevicesSan Diego, US

Stephen(Co-founder, EVP Research & Development and Chief Development Officer)Paul Cayer(Chief Financial Officer)inVikram(President and Chief Executive Officer)Kimberly(Chief Scientific Officer)Quentin(Chief Technical Officer)

Co-investorsFOForesite CapitalLOLongwood FundNONorwest Venture PartnersPIPivotal Life SciencesRIRiverVest Venture PartnersYSYsios Capital+4 more

Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.

BiotechHealthtechNewton, US

Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Founder)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)

Co-investorsBABain Capital Life SciencesNENew Enterprise Associates (NEA)RARA CapitalSASamsara BioCapitalSASanofi VenturesMAMass General Brigham Ventures+9 more

AgelessRx offers prescription weight management medications delivered through a telehealth platform, including GLP-1 medications (semaglutide, tirzepatide), FDA-approved weight loss drugs (Wegovy, Zepbound), and supportive treatments like metformin and vitamin injections for adults seeking medically-supervised weight loss.

BiotechDigital HealthDirect to ConsumerHealthtechLongevityAnn Arbor, US

AIAnar Isman(Co-Founder & Chief Executive Officer)inRobert Michael Pejovich(Director of Finance of the Issuer)

Co-investors1/1/1 CapitalANAngelini VenturesFIFidelity InvestmentsJAJanus Henderson InvestorsSASanofi Ventures

Alpha-9 Oncology develops radiopharmaceuticals for cancer treatment, with a portfolio of molecules in clinical and preclinical development.

BiotechDigital HealthMedical DevicesVancouver, CA

FBFrançois Bénard(Founder)KLKuo-Shyan Lin(Founder)DPDavid Perrin(Founder)

Co-investorsANAndreessen HorowitzASAscenta CapitalDEDelos CapitalFRFrazier Life SciencesGEGeneral CatalystLILightspeed Venture Partners+9 more

Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology.

BiotechDeep TechHealthtechMedical Devices

Co-investorsF-F-Prime CapitalNONovartis Venture FundRIRiverVest Venture PartnersSASanofi VenturesEQEQT Life Sciences

Epic CRISPR develops GEMS (Gene Expression Modulation System), a modular epigenetic editing platform that combines DNA-binding proteins, guide RNAs, and modulator proteins to create genetic medicines.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US

Lei Stanley Qi(Scientific Founder)inASAmber Salzman(Executive Officer, Director)inHaorui Zhang(Executive Officer, Director)

BoardAndrew Lam(Director)Anran Li(Director)Jennifer King(Director)

Co-investorsALAlly Bridge GroupSASanofi VenturesANAngelini VenturesFIFidelity InvestmentsJAJanus Henderson Investors

Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options.

BiotechSan Francisco, US

Agnes Rafalko(Executive Officer, Director)inSASteven Axon(Chief Executive Officer)inHAHicham Alaoui(Chief Scientific Officer)inRMRose Marino(Chief Medical Officer)inPMPeter McWilliams(Chief Business Officer)GHGeoffrey Hird(Chief Technology Officer)in

Co-investorsADAdvent Life SciencesASAsahi Kasei Corporate Venture CapitalCHChiesi VenturesCTCTI Life Sciences Fund L.P.MIMission Bay CapitalMIMission Biocapital+6 more

Matter is a real estate investment firm focused on the living sector, investing across sub-sectors such as single- and multi-family, senior living, and affordable housing.

Impact & Social GoodPropTech

DCDavid Christie(CEO)in

Co-investorsGCGCM GrosvenorUBUBS

Nuvig Therapeutics is a biotech company developing immune-modulating therapies for autoimmune and chronic inflammatory diseases, using an endogenous regulatory mechanism intended to treat inflammation without compromising broader immune function.

BiotechLongevity

Co-investorsSASanofi VenturesALAlexandriaB B CapitalDIDigitalis VenturesGLGlobal BioAccess FundLELeaps by Bayer+4 more

Qlaris Bio is a clinical-stage biotechnology company developing therapies for ophthalmology conditions.

BiotechMedical DevicesDedham, US

Thurein Htoo(Executive Officer, Director)inFGFred Guerard(President & Chief Executive Officer)inBWBarbara Wirostko(Executive Officer)

BoardWHWende Hutton(Director)inRonald M. Hunt(Director)Andrew Danielson(Director)

Co-investorsCACanaan PartnersCOCorrelation VenturesMAMayo Clinic VenturesNENew Leaf Venture Partners

Third Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering.

BiotechMedical DevicesLower Gwynedd, US

Joseph Erhardt(Executive Officer)inPeter Lebowitz(Executive Officer, Director)

BoardAGArjun Goyal(Director)inOtello Stampacchia(Director)inFDFrancesco Draetta(Director)in

Co-investorsANAndreessen HorowitzVIVida VenturesBIBiotechnology Value FundFOForesite CapitalHIHillhouse InvestmentOMOmega Funds+1 more

Titanbay provides infrastructure technology connecting asset managers and distributors to manage private market funds, handling fund structuring, onboarding, capital flows, reporting, and compliance at scale.

Enterprise SoftwareFintechSaaSLuxembourg, LU

MGMichael Gruenerin

Co-investorsMOMotive Partners